2S [LEC]: Transplantation Flashcards
Transfer of cells, tissue, or organs from one part of the body or from one individual to another
Transplantation
The material to be transferred
Graft/ transplant
A lifesaving treatment for end-stage organ failure, cancers, autoimmune disorders, and other disease
Transplantation (grafting)
The most important antigen causing graft rejection
Human Leukocyte Antigen (HLA)
The MHC is located on what chromosome?
Chromosome 6
Most important Class I MHC
HLA-A and HLA-B
Proteins that is involved in gamma or delta T-cell responses
MHC Class I-related Chain A (MICA) Antigens
T/F: MICA antigens are expressed on all nucleated cells, T cells, and B cells
False (MICA is only expressed on nucleated cells, not on T or B cells)
Target for allograft immune response
MHC Class I-related Chain A (MICA) Antigens
Incompatibility leads to hyperacute graft rejection
ABO blood group antigens
Important barrier to solid organ transplants
ABO blood group antigens
Cell surface molecules that regulate NK cells
Killer Immunoglobulin-Like Receptors (KIRs)
MHC class associated with Killer Immunoglobulin-Like Receptors (KIRs)
MHC Class I
Humoral IR targeting self antigens that can lead to poor transplant outcomes
Self antigens
Transplantation that elicit no immune response and has the highest chance of graft survival
Autograft
Transplantation that occurs between two different but identical individuals, like in the case of identical twins
Isograft or Syngraft
Transplantation that occurs from one person to another, or of the same species
Allograft/ Homograft
Transplantation where the graft is coming from an animal or a different species
Xenograft
Graft transplanted from one place on the donor to the same place on the recipient
Orthotopic
Graft transplanted from one place on the donor to a different site on the recipient
Heterotopic
Graft property wherein the growth of the transplanted graft does not occur
Homostatic
Graft property wherein tissue growth after transplantation takes place
Homovital
Heart donation has a high chance of survival and is transplanted within how many hours?
4
Most immunogenic organ/tissue
Bone marrow
Least immunogenic organ/tissue
Cornea
Organs that have lower chances of being associated with GVHD
Kidney and Liver
Mechanism of graft rejection which causes thrombotic occlusion and preformed antibodies are involved, binding to donor blood vessels
Hyperacute rejection
Mechanism of graft rejection which causes damage of blood vessels of parenchyma
Acute cellular rejection
Primary cell involved in acute cellular rejection
Cytotoxic T cell
The dominant lesion present in chronic rejection
Arterial occlusion
Identify the type of graft rejection based on the mechanism:
Preformed antibodies to ABO, HLA, and certain endothelial antigens bind to donor vascular endothelium, activating complement and clotting factors
Hyperacute
Identify the type of graft rejection based on the mechanism:
Leads to thrombus formation, ischemia, and necrosis of transplanted tissue
Hyperacute
Identify the type of graft rejection based on the mechanism:
Same as for hyperacute rejection, but takes days instead of minutes to hours due to very low levels of donor-specific antibodies
Accelerated
Identify the type of graft rejection based on the mechanism:
Cell-mediated response to foreign MHC-expressing cells, where CD4+ T cells produce cytokines and induce delayed type hypersenstivity
Acute
Identify the type of graft rejection based on the mechanism:
Antibodies produced against HLA antigens bind to vessel walls, activate complement, and induce transmural necrosis and inflammation
Acute
Identify the type of graft rejection based on the mechanism:
Delayed type hypersensitivity response, and possibly antibodies, to foreign HLA antigens on graft
Chronic
Identify the type of graft rejection based on the mechanism:
Graft arteriosclerosis and smooth muscle proliferation occur, resulting in fibrosis, scarring, and narrowing of vessel lumen
Chronic
Identify the type of graft rejection:
Occurs within 100 days or more
Graft-versus-host disease (GVHD)
Identify the type of graft rejection based on the mechanism:
T cells in HSC, lung, or liver transplants react against foreign HLA proteins in the recipient’s cells, causing massive cytokine release, inflammation, and tissue destruction in various locations throughout the body
Graft-versus-host disease (GVHD)
Oldest form of transplantation
Blood transfusion
Allogeneic response seen in HSC transplants
GVHD
Type of GVHD that causes epithelial cell death in the skin, intestinal tract, and live, and may be fatal
Acute GVHD
Type of GVHD that causes fibrosis and atrophy of one or more of these same target organs as well as the lungs and may also be fatal
Chronic GVHD
The prevent and manage GVHD, what is done to patients in the early post transplant period?
Immunosuppressive therapy
Which immune cells are primarily removed in immunosuppressive therapy?
T cells
Ultimate goal of organ transplantation
Graft acceptance
T/F: Solid organs for transplant can come from both living and deceased donors
True
Organ transplant where a larger number of matched MHC alleles has a better graft survival
Kidney transplant
Main stay in prevention and treatment of graft rejection
Immunosuppression
Identify the immunosuppressant class:
Potent anti-inflammatory and immunosuppressive agent, but prolonged use increases the chances of developing diabetes mellitus and hypertension
Corticosteroids
Identify the immunosuppressant class:
Blocks the production of cytokines and may act as chemoattractant
Corticosteroids
Identify the immunosuppressant:
1st agent approved; interferes with lymphocyte maturation and kill proliferating cells
Azathioprine (antimetabolite)
Identify the immunosuppressant:
Blocks signal transduction in T cells, leading to impaired synthesis of cytokines
Cyclosporine and Tacrolimus (Calcineurin inhibitors)
Identify the immunosuppressant class:
Blocks the activation of NFAT transcription factor
Calcineurin inhibitors
Identify the immunosuppressant:
Inhibits T-cell proliferation by binding to specific intracellular proteins
Rapamycin (Sirolimus) (Calcineurin inhibitors)
Identify the immunosuppressant class:
Binds to cell surface molecules; used at the time of transplantation and for treatment of severe rejection episodes after transplantation
Monoclonal antibodies
Identify the immunosuppressant:
Binds to CD25 (IL2 receptor)
Basiliximab (Monoclonal antibody)
Identify the immunosuppressant:
Binds to CD52 receptor; for induction therapy during transplantation
Alemtuzumab (Monoclonal antibody)
Identify the immunosuppressant class:
Depletes lymphocytes from circulation
Polyclonal antibodies
Identify the immunosuppressant:
Antithymocyte Ab prepared from rabbits
Thymoglobulin (Polyclonal antibody)
Identify the immunosuppressant:
Polyclonal antiserum prepared from immunized horses
ATGAM (Anti-thymocyte Globulin [Equine])
Identify the immunosuppressant class:
Prevents the delivery of costimulatory signals required for activation of T cells, reducing acute graft rejection
Costimulatory blockade
Identify the immunosuppressant:
Binds to B7 molecules on APCs and prevents them from interacting with T cell CD28
CTLA4Ig (Belatacept) (Costimulatory blockade)
Phenotypic or genotypic identification of the HLA antigens or genes in a transplant candidate or donor
HLA typing
Principle of HLA phenotyping
Complement-dependent cytotoxicity (CDC)
PCR-based amplification of HLA genes followed by analysis of the amplified DNA to identify the specific HLA allele or allele group
HLA genotyping
The gold standard for HLA genotyping
PCR-SBT (Polymerase Chain Reaction with Sequence-Based Typing)
The only technique that directly detects the nucleotide sequence of an allele
PCR-SBT (Polymerase Chain Reaction with Sequence-Based Typing)
Used as a predictive test for T-cell mediated rejection
Mixed lymphocyte reaction
An HLA mismatch will have what result in the mixed lymphocyte reaction?
Positive
This method checks the immunological incompatibility of the donor and recipient before transplantations using thymidine as an indicator or label
Mixed lymphocyte culture